Vijayan Venugopal
Bedong, 08100, Malaysia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
New pyrrolopyridine-based thiazolotriazoles as diabetics inhibitors: enzymatic kinetics and in silico study.
Journal: Future medicinal chemistry
Published: April 04, 2023
Mechanistic insights into the beneficial effects of curcumin on insulin resistance: Opportunities and challenges.
Journal: Drug discovery today
Published: February 15, 2023
Syntheses, in vitro, and in silico studies of rhodanine-based schiff bases as potential α-amylase inhibitors and radicals (DPPH and ABTS) scavengers.
Journal: Molecular diversity
Published: March 27, 2022
Synthesis of indole derivatives as diabetics II inhibitors and enzymatic kinetics study of α-glucosidase and α-amylase along with their in-silico study.
Journal: International journal of biological macromolecules
Published: June 28, 2021
Green Synthesis and Characterization of Silver Nanoparticles Using Spondias mombin Extract and Their Antimicrobial Activity against Biofilm-Producing Bacteria.
Journal: Molecules (Basel, Switzerland)
Published: March 28, 2021
Dihydroquinazolin-4(1H)-one derivatives as novel and potential leads for diabetic management.
Journal: Molecular diversity
Published: April 12, 2020
Synthesis, in vitro α-amylase inhibitory, and radicals (DPPH & ABTS) scavenging potentials of new N-sulfonohydrazide substituted indazoles.
Journal: Bioorganic chemistry
Published: September 24, 2019
Synthesis of benzotriazoles derivatives and their dual potential as α-amylase and α-glucosidase inhibitors in vitro: Structure-activity relationship, molecular docking, and kinetic studies.
Journal: European journal of medicinal chemistry
Published: June 14, 2019
Anti-EGFR anchored paclitaxel loaded PLGA nanoparticles for the treatment of triple negative breast cancer. In-vitro and in-vivo anticancer activities.
Journal: PloS one
Published: June 19, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026